Lessons from sleepy mice

Narcolepsy-cataplexy and the orexin neuropeptide system

Jon T. Willie, Masashi Yanagisawa

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Narcolepsy-cataplexy consists of two underlying problems: (i) inability to maintain wakefulness, and (ii) intrusion of features of REM sleep into wakefulness or at sleep onset. Together these result in the symptom complex of excessive daytime sleepiness accompanied by irresistible “sleep attacks,” cataplexy, sleep-onset hallucinations, and sleep paralysis. A reliable diagnostic sign is that of “sleep-onset REM sleep” (SOREM) periods during polysomnographic recordings of daytime naps. Narcolepsycataplexy, in the vast majority of human cases, results from selective loss of hypothalamic neurons containing orexin (hypocretin) neuropeptides, possibly by an autoimmune process. The neuropeptides orexin-A and orexin-B are products of the prepro-orexin (prepro-hypocretin) gene that is expressed by a population of neurons in the lateral hypothalamic area (LHA). Notably, orexin neurons send projections throughout the brain and spinal cord with particularly dense innervations of monoaminergic and cholinergic centers controlling sleep-wake in the forebrain and brainstem. Orexin peptides are endogenous ligands for two G protein-coupled receptors termed orexin receptors type 1 and type 2 (OX1R and OX2R), and a number of studies have suggested that orexin peptides are primarily neuroexcitatory. OX1Rs exhibit moderately higher affinity for orexin-A while OX2Rs exhibit equal affinity for both orexin-A and orexin-B. The differential distribution of the two orexin receptors suggests distinct roles of each receptor in aspects of vigilance state control and muscle tone.

Original languageEnglish (US)
Title of host publicationNarcolepsy and Hypersomnia
PublisherCRC Press
Pages257-278
Number of pages22
ISBN (Electronic)9781420019254
ISBN (Print)9780849337154
StatePublished - Jan 1 2006

Fingerprint

Cataplexy
Narcolepsy
Neuropeptides
Orexin Receptors
Sleep
Wakefulness
REM Sleep
Neurons
Sleep Paralysis
Lateral Hypothalamic Area
Peptides
Hallucinations
Prosencephalon
G-Protein-Coupled Receptors
Orexins
Cholinergic Agents
Brain Stem
Spinal Cord
Ligands
Muscles

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Willie, J. T., & Yanagisawa, M. (2006). Lessons from sleepy mice: Narcolepsy-cataplexy and the orexin neuropeptide system. In Narcolepsy and Hypersomnia (pp. 257-278). CRC Press.

Lessons from sleepy mice : Narcolepsy-cataplexy and the orexin neuropeptide system. / Willie, Jon T.; Yanagisawa, Masashi.

Narcolepsy and Hypersomnia. CRC Press, 2006. p. 257-278.

Research output: Chapter in Book/Report/Conference proceedingChapter

Willie, JT & Yanagisawa, M 2006, Lessons from sleepy mice: Narcolepsy-cataplexy and the orexin neuropeptide system. in Narcolepsy and Hypersomnia. CRC Press, pp. 257-278.
Willie JT, Yanagisawa M. Lessons from sleepy mice: Narcolepsy-cataplexy and the orexin neuropeptide system. In Narcolepsy and Hypersomnia. CRC Press. 2006. p. 257-278
Willie, Jon T. ; Yanagisawa, Masashi. / Lessons from sleepy mice : Narcolepsy-cataplexy and the orexin neuropeptide system. Narcolepsy and Hypersomnia. CRC Press, 2006. pp. 257-278
@inbook{d07de9fa580749fd80e2cd051d181513,
title = "Lessons from sleepy mice: Narcolepsy-cataplexy and the orexin neuropeptide system",
abstract = "Narcolepsy-cataplexy consists of two underlying problems: (i) inability to maintain wakefulness, and (ii) intrusion of features of REM sleep into wakefulness or at sleep onset. Together these result in the symptom complex of excessive daytime sleepiness accompanied by irresistible “sleep attacks,” cataplexy, sleep-onset hallucinations, and sleep paralysis. A reliable diagnostic sign is that of “sleep-onset REM sleep” (SOREM) periods during polysomnographic recordings of daytime naps. Narcolepsycataplexy, in the vast majority of human cases, results from selective loss of hypothalamic neurons containing orexin (hypocretin) neuropeptides, possibly by an autoimmune process. The neuropeptides orexin-A and orexin-B are products of the prepro-orexin (prepro-hypocretin) gene that is expressed by a population of neurons in the lateral hypothalamic area (LHA). Notably, orexin neurons send projections throughout the brain and spinal cord with particularly dense innervations of monoaminergic and cholinergic centers controlling sleep-wake in the forebrain and brainstem. Orexin peptides are endogenous ligands for two G protein-coupled receptors termed orexin receptors type 1 and type 2 (OX1R and OX2R), and a number of studies have suggested that orexin peptides are primarily neuroexcitatory. OX1Rs exhibit moderately higher affinity for orexin-A while OX2Rs exhibit equal affinity for both orexin-A and orexin-B. The differential distribution of the two orexin receptors suggests distinct roles of each receptor in aspects of vigilance state control and muscle tone.",
author = "Willie, {Jon T.} and Masashi Yanagisawa",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780849337154",
pages = "257--278",
booktitle = "Narcolepsy and Hypersomnia",
publisher = "CRC Press",

}

TY - CHAP

T1 - Lessons from sleepy mice

T2 - Narcolepsy-cataplexy and the orexin neuropeptide system

AU - Willie, Jon T.

AU - Yanagisawa, Masashi

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Narcolepsy-cataplexy consists of two underlying problems: (i) inability to maintain wakefulness, and (ii) intrusion of features of REM sleep into wakefulness or at sleep onset. Together these result in the symptom complex of excessive daytime sleepiness accompanied by irresistible “sleep attacks,” cataplexy, sleep-onset hallucinations, and sleep paralysis. A reliable diagnostic sign is that of “sleep-onset REM sleep” (SOREM) periods during polysomnographic recordings of daytime naps. Narcolepsycataplexy, in the vast majority of human cases, results from selective loss of hypothalamic neurons containing orexin (hypocretin) neuropeptides, possibly by an autoimmune process. The neuropeptides orexin-A and orexin-B are products of the prepro-orexin (prepro-hypocretin) gene that is expressed by a population of neurons in the lateral hypothalamic area (LHA). Notably, orexin neurons send projections throughout the brain and spinal cord with particularly dense innervations of monoaminergic and cholinergic centers controlling sleep-wake in the forebrain and brainstem. Orexin peptides are endogenous ligands for two G protein-coupled receptors termed orexin receptors type 1 and type 2 (OX1R and OX2R), and a number of studies have suggested that orexin peptides are primarily neuroexcitatory. OX1Rs exhibit moderately higher affinity for orexin-A while OX2Rs exhibit equal affinity for both orexin-A and orexin-B. The differential distribution of the two orexin receptors suggests distinct roles of each receptor in aspects of vigilance state control and muscle tone.

AB - Narcolepsy-cataplexy consists of two underlying problems: (i) inability to maintain wakefulness, and (ii) intrusion of features of REM sleep into wakefulness or at sleep onset. Together these result in the symptom complex of excessive daytime sleepiness accompanied by irresistible “sleep attacks,” cataplexy, sleep-onset hallucinations, and sleep paralysis. A reliable diagnostic sign is that of “sleep-onset REM sleep” (SOREM) periods during polysomnographic recordings of daytime naps. Narcolepsycataplexy, in the vast majority of human cases, results from selective loss of hypothalamic neurons containing orexin (hypocretin) neuropeptides, possibly by an autoimmune process. The neuropeptides orexin-A and orexin-B are products of the prepro-orexin (prepro-hypocretin) gene that is expressed by a population of neurons in the lateral hypothalamic area (LHA). Notably, orexin neurons send projections throughout the brain and spinal cord with particularly dense innervations of monoaminergic and cholinergic centers controlling sleep-wake in the forebrain and brainstem. Orexin peptides are endogenous ligands for two G protein-coupled receptors termed orexin receptors type 1 and type 2 (OX1R and OX2R), and a number of studies have suggested that orexin peptides are primarily neuroexcitatory. OX1Rs exhibit moderately higher affinity for orexin-A while OX2Rs exhibit equal affinity for both orexin-A and orexin-B. The differential distribution of the two orexin receptors suggests distinct roles of each receptor in aspects of vigilance state control and muscle tone.

UR - http://www.scopus.com/inward/record.url?scp=84892870509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892870509&partnerID=8YFLogxK

M3 - Chapter

SN - 9780849337154

SP - 257

EP - 278

BT - Narcolepsy and Hypersomnia

PB - CRC Press

ER -